Autobio Diagnostics Co., Ltd. (SHA:603658)
31.14
-0.99 (-3.08%)
Sep 11, 2026, 3:00 PM CST
Autobio Diagnostics Revenue
Autobio Diagnostics had revenue of 1.07B CNY in the quarter ending June 30, 2026, with 0.13% growth. This brings the company's revenue in the last twelve months to 4.22B, down -2.32% year-over-year. In the year 2025, Autobio Diagnostics had annual revenue of 4.23B, down -5.47%.
Revenue (ttm)
4.22B
Revenue Growth
-2.32%
P/S Ratio
4.21
Revenue / Employee
741.06K
Employees
5,700
Market Cap
17.79B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.23B | -244.79M | -5.47% |
| Dec 31, 2024 | 4.47B | 27.55M | 0.62% |
| Dec 31, 2023 | 4.44B | 2.03M | 0.05% |
| Dec 31, 2022 | 4.44B | 675.71M | 17.94% |
| Dec 31, 2021 | 3.77B | 787.79M | 26.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Yuyue Medical Equipment & Supply | 7.87B |
| Lepu Medical Technology (Beijing) | 6.33B |
| Cofoe Medical Technology | 3.96B |
| Shandong Weigao Blood Purification Products | 3.76B |
| MGI Tech | 3.00B |
| Double Medical Technology | 2.73B |
| Jafron Biomedical | 1.91B |
| MeHow Innovative | 1.71B |
Autobio Diagnostics News
- 20 days ago - Autobio Diagnostics Quarterly report: Q2 2026 - Filings
- 4 months ago - Autobio Diagnostics Annual report: Q4 2025 - Filings
- 4 months ago - Autobio Diagnostics Quarterly report: Q1 2026 - Filings
- 10 months ago - Autobio Diagnostics Quarterly report: Q3 2025 - Filings